Medicine & Life Sciences
Pharmacokinetics
100%
Pharmaceutical Preparations
29%
eldecalcitol
28%
Digoxin
27%
Genotype
21%
Drug Monitoring
20%
Osteoporosis
19%
Respiratory Tract Infections
19%
Non-Small Cell Lung Carcinoma
19%
Population
18%
ATP Binding Cassette Transporter, Subfamily B, Member 1
18%
Cytochrome P-450 CYP2C19
17%
sitafloxacin
17%
arbekacin
17%
Reduced Folate Carrier Protein
16%
Clinical Studies
16%
Neoplasms
16%
Micafungin
15%
Sulfasalazine
14%
Neutropenia
14%
Safety
14%
Bone Density
13%
Kidney
13%
Area Under Curve
13%
Zoledronic Acid
13%
Tartrate-Resistant Acid Phosphatase
13%
Methylenetetrahydrofolate Reductase (NADPH2)
13%
Therapeutics
13%
Voriconazole
13%
Cytochrome P-450 CYP2D6
13%
Gefitinib
13%
Levofloxacin
12%
Omeprazole
12%
Itraconazole
12%
Vinblastine
12%
Cholecalciferol
12%
Japan
11%
TAK 603
11%
Multiple Drug Resistance
11%
Transcytosis
11%
Fluorouracil
11%
edotecarin
11%
Tamoxifen
11%
Neutrophils
10%
Methicillin-Resistant Staphylococcus aureus
10%
Mycoses
10%
Pediatrics
10%
Drug-Related Side Effects and Adverse Reactions
10%
Clinical Pharmacology
10%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10%
Neoplastic Stem Cells
10%
N-desmethylclobazam
10%
Methotrexate
10%
Renal Cell Carcinoma
10%
Breast Neoplasms
9%
LLC-PK1 Cells
9%
Genetic Polymorphisms
9%
mepirodipine
9%
Nicardipine
9%
Serum
9%
alfacalcidol
9%
Serum Albumin
9%
Streptococcus pneumoniae
9%
fropenem
9%
garenoxacin
9%
Drug Interactions
9%
lenvatinib
8%
eribulin
8%
Sulfapyridine
8%
Axitinib
8%
Clobazam
8%
Chronic Disease
8%
130-nm albumin-bound paclitaxel
8%
Tsunamis
7%
Maintenance Chemotherapy
7%
Tacrolimus
7%
Topoisomerase I Inhibitors
7%
Aspergillosis
7%
Teriparatide
7%
Hemoperfusion
7%
Natural Disasters
7%
Meropenem
7%
Antineoplastic Agents
7%
Antihypertensive Agents
7%
Diazoxide
7%
Daunorubicin
7%
Microbial Sensitivity Tests
7%
Healthy Volunteers
7%
Clinical Trials
6%
Suppositories
6%
Body Surface Area
6%
Community-Acquired Infections
6%
Earthquakes
6%
Pemetrexed
6%
Paraquat
6%
Glucuronosyltransferase
6%
Alleles
6%
Uridine Diphosphate
6%
Acetyltransferases
6%
Xanthine
6%
Chemical Compounds
Pharmacokinetics
29%
Digoxin
27%
Drug
18%
Gefitinib
16%
Itraconazole
15%
Omeprazole
14%
Dose
14%
Nicardipine
11%
Barnidipine
10%
Superoxide
10%
Micafungin
9%
Antianginal
9%
Metabolite
9%
Everolimus
9%
Plasma Concentration
8%
Sulfapyridine
8%
Antirheumatic Agent
8%
Evans Blue
8%
Suppository
8%
EC 5.99.1.2 (DNA Topoisomerase) Inhibitor
8%
Pindolol
8%
Intragastric
7%
Antiarrhythmic Agent
7%
Verapamil
6%
Clearance
6%
Resistance
6%
Metabolic
6%
Fibrin
6%
Antihypertensive
6%
Charcoal
6%
Xanthine
5%
Complementary DNA
5%
Molecular Size
5%
Interstitial
5%
Dosage Form
5%
Alginate
5%
Acetylation
5%